Viridian Therapeutics, Inc.\DE Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • Viridian Therapeutics, Inc.\DE Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 66.4M shares, a 52.1% increase year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 44.8M shares, a 39.5% increase from 2022.
  • Viridian Therapeutics, Inc.\DE annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 32.1M shares, a 169% increase from 2021.
  • Viridian Therapeutics, Inc.\DE annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 11.9M shares, a 235% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 44.8M +12.7M +39.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 32.1M +20.2M +169% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 11.9M +8.36M +235% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 3.56M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.